{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:22:08Z","timestamp":1747207328301,"version":"3.40.5"},"reference-count":104,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPR"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>With the increased discovery of genes implicated in vitamin D metabolism and the regu-lation of calcium and phosphate homeostasis, a growing number of genetic forms of rickets are now recognized. These are categorized into calciopenic and phosphopenic rickets. Calciopenic forms of hereditary rickets are caused by genetic mutations that alter the enzymatic activity in the vitamin D activation pathway or impair the vitamin D receptor action. Hereditary forms of phosphopenic rick-ets, on the other hand, are caused by genetic mutations that lead to increased expression of FGF23 hormone or that impair the absorptive capacity of phosphate at the proximal renal tubule. Due to the clinical overlap between acquired and genetic forms of rickets, identifying children with hereditary rickets can be challenging. A clear understanding of the molecular basis of hereditary forms of rick-ets and their associated biochemical patterns allow the health care provider to assign the correct di-agnosis, avoid non-effective interventions and shorten the duration of the diagnostic journey in these children. In this mini-review, known forms of hereditary rickets listed on the Online Mendeli-an Inheritance in Man database are discussed. Further, a clinical approach to identify and diagnose children with hereditary forms of rickets is suggested.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573396319666221205123402","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T07:25:16Z","timestamp":1670397916000},"page":"380-394","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hereditary Rickets: A Quick Guide for the Pediatrician"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5736-0793","authenticated-orcid":true,"given":"Abdulmajeed","family":"AlSubaihin","sequence":"first","affiliation":[{"name":"Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia"},{"name":"King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Harrington","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Women's and Children's Health Network, North Adelaide, Australia"},{"name":"Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1177\/000992288001900305","volume":"19","author":"Cone T.E.","year":"1980","unstructured":"Cone T.E.; A rachitic infant painted by Burgkmair 136 years before Dr. Whistler described rickets. Clin Pediatr  1980,19(3),194","journal-title":"Clin Pediatr"},{"key":"ref=2","first-page":"45","volume":"36","author":"Clarke E.","year":"1962","unstructured":"Clarke E.; Whistler and Glisson on rickets. Bull Hist Med  1962,36,45-61","journal-title":"Bull Hist Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"F154","DOI":"10.1136\/fn.78.2.F154","volume":"78","author":"Dunn P.M.","year":"1998","unstructured":"Dunn P.M.; Francis Glisson (1597-1677) and the \u201cdiscovery\u201d of rickets. Arch Dis Child Fetal Neonatal Ed  1998,78(2),F154-F155","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1007\/s00467-019-04366-9","volume":"35","author":"Friedman A.","year":"2020","unstructured":"Friedman A.; A brief history of rickets. Pediatr Nephrol  2020,35(10),1835-1841","journal-title":"Pediatr Nephrol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1080\/20469047.2016.1248170","volume":"37","author":"Creo A.L.","year":"2017","unstructured":"Creo A.L.; Thacher T.D.; Pettifor J.M.; Strand M.A.; Fischer P.R.; Nutritional rickets around the world: An update. Paediatr Int Child Health  2017,37(2),84-98","journal-title":"Paediatr Int Child Health"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1530\/EJE-08-0818","volume":"160","author":"Beck-Nielsen S.S.","year":"2009","unstructured":"Beck-Nielsen S.S.; Brock-Jacobsen B.; Gram J.; Brixen K.; Jensen T.K.; Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol  2009,160(3),491-497","journal-title":"Eur J Endocrinol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/1753-6405.12390","volume":"39","author":"Wheeler B.J.","year":"2015","unstructured":"Wheeler B.J.; Dickson N.P.; Houghton L.A.; Ward L.M.; Taylor B.J.; Incidence and characteristics of vitamin D deficiency rickets in New Zea-land children: a New Zealand Paediatric Surveillance Unit study. Aust N Z J Public Health  2015,39(4),380-383","journal-title":"Aust N Z J Public Health"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"466","DOI":"10.5694\/mja11.10662","volume":"196","author":"Munns C.F.","year":"2012","unstructured":"Munns C.F.; Simm P.J.; Rodda C.P.; Incidence of vitamin D deficiency rickets among Australian children: An Australian Paediatric Sur-veillance Unit study. Med J Aust  2012,196(7),466-468","journal-title":"Med J Aust"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/archdischild-2019-317934","volume":"105","author":"Julies P.","year":"2020","unstructured":"Julies P.; Lynn R.M.; Pall K.; Nutritional rickets under 16 years: UK surveillance results. Arch Dis Child  2020,105(6),587-592","journal-title":"Arch Dis Child"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1507\/endocrj.EJ18-0008","volume":"65","author":"Kubota T.","year":"2018","unstructured":"Kubota T.; Nakayama H.; Kitaoka T.; Incidence rate and characteristics of symptomatic vitamin D deficiency in children: A nationwide survey in Japan. Endocr J  2018,65(6),593-599","journal-title":"Endocr J"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1503\/cmaj.061377","volume":"177","author":"Ward L.M.","year":"2007","unstructured":"Ward L.M.; Gaboury I.; Ladhani M.; Zlotkin S.; Vitamin D-deficiency rickets among children in Canada. CMAJ  2007,177(2),161-166","journal-title":"CMAJ"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e015289","DOI":"10.1136\/bmjopen-2016-015289","volume":"7","author":"Meyer H.E.","year":"2017","unstructured":"Meyer H.E.; Skram K.; Berge I.A.; Madar A.A.; Bj\u00f8rndalen H.J.; Nutritional rickets in Norway: A nationwide register-based cohort study. BMJ Open  2017,7(5),e015289","journal-title":"BMJ Open"},{"key":"ref=13","unstructured":"An online catalog of human genes and genetic disorder: Available from:  www.omim.org (Accessed on: Jan 1, 2022)."},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.chembiol.2013.12.016","volume":"21","author":"Bikle D.D.","year":"2014","unstructured":"Bikle D.D.; Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol  2014,21(3),319-329","journal-title":"Chem Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7711","DOI":"10.1073\/pnas.0402490101","volume":"101","author":"Cheng J.B.","year":"2004","unstructured":"Cheng J.B.; Levine M.A.; Bell N.H.; Mangelsdorf D.J.; Russell D.W.; Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA  2004,101(20),7711-7715","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"E2022","DOI":"10.1210\/jc.2012-1340","volume":"97","author":"Al Mutair A.N.","year":"2012","unstructured":"Al Mutair A.N.; Nasrat G.H.; Russell D.W.; Mutation of the CYP2R1 vitamin D 25-hydroxylase in a Saudi Arabian family with severe vitamin D deficiency. J Clin Endocrinol Metab  2012,97(10),E2022-E2025","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jbmr.3181","volume":"32","author":"Molin A.","year":"2017","unstructured":"Molin A.; Wiedemann A.; Demers N.; Vitamin D-dependent rickets type 1B (25-Hydroxylase Deficiency): A rare condition or a misdi-agnosed condition? J Bone Miner Res  2017,32(9),1893-1899","journal-title":"J Bone Miner Res"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"E1005","DOI":"10.1210\/jc.2015-1746","volume":"100","author":"Thacher T.D.","year":"2015","unstructured":"Thacher T.D.; Fischer P.R.; Singh R.J.; Roizen J.; Levine M.A.; CYP2R1 Mutations impair generation of 25-hydroxyvitamin D and cause an atypical form of vitamin D deficiency. J Clin Endocrinol Metab  2015,100(7),E1005-E1013","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s12020-021-02670-9","volume":"72","author":"Ozden A.","year":"2021","unstructured":"Ozden A.; Doneray H.; Turkyilmaz A.; Two novel CYP2R1 mutations in a family with vitamin D-dependent rickets type 1b. Endocrine  2021,72(3),852-864","journal-title":"Endocrine"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jsbmb.2016.07.014","volume":"173","author":"Thacher T.D.","year":"2017","unstructured":"Thacher T.D.; Levine M.A.; CYP2R1 mutations causing vitamin D-deficiency rickets. J Steroid Biochem Mol Biol  2017,173,333-336","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1530\/EC-21-0102","volume":"10","author":"Bakhamis S.","year":"2021","unstructured":"Bakhamis S.; Imtiaz F.; Ramzan K.; 25-Hydroxylase vitamin D deficiency in 27 Saudi Arabian subjects: A clinical and molecular re-port on CYP2R1 mutations. Endocr Connect  2021,10(7),767-775","journal-title":"Endocr Connect"},{"key":"ref=22","first-page":"1961","volume":"11","author":"Fu G.K.","year":"1997","unstructured":"Fu G.K.; Lin D.; Zhang M.Y.; Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol  1997,11(13),1961-1970","journal-title":"Mol Endocrinol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJM199803053381004","volume":"338","author":"Kitanaka S.","year":"1998","unstructured":"Kitanaka S.; Takeyama K.; Murayama A.; Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med  1998,338(10),653-662","journal-title":"N Engl J Med"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1007\/s00223-016-0165-z","volume":"99","author":"Koek W.N.H.","year":"2016","unstructured":"Koek W.N.H.; Zillikens M.C.; van der Eerden B.C.J.; van Leeuwen J.P.T.M.; Novel compound heterozygous mutations in the CYP27B1 gene lead to pseudovitamin D-deficient rickets. Calcif Tissue Int  2016,99(3),326-331","journal-title":"Calcif Tissue Int"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1210\/jc.2010-1340","volume":"96","author":"Edouard T.","year":"2011","unstructured":"Edouard T.; Alos N.; Chabot G.; Roughley P.; Glorieux F.H.; Rauch F.; Short- and long-term outcome of patients with pseudo-vitamin D defi-ciency rickets treated with calcitriol. J Clin Endocrinol Metab  2011,96(1),82-89","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e0131376","DOI":"10.1371\/journal.pone.0131376","volume":"10","author":"Demir K.","year":"2015","unstructured":"Demir K.; Kattan W.E.; Zou M.; Novel CYP27B1 gene mutations in patients with vitamin D-dependent rickets type 1A. PLoS One  2015,10(7),e0131376","journal-title":"PLoS One"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000444483","volume":"85","author":"Tahir S.","year":"2016","unstructured":"Tahir S.; Demirbilek H.; Ozbek M.N.; Baran R.T.; Tanriverdi S.; Hussain K.; Genotype and phenotype characteristics in 22 patients with vita-min D-dependent rickets type I. Horm Res Paediatr  2016,85(5),309-317","journal-title":"Horm Res Paediatr"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4274\/jcrpe.galenos.2018.2018.0121","volume":"11","author":"Dursun F.","year":"2019","unstructured":"Dursun F.; \u00d6zg\u00fcrhan G.; K\u0131rm\u0131z\u0131bekmez H.; Keskin E.; Hac\u0131hamdio\u011flu B.; Genetic and clinical characteristics of patients with vitamin D de-pendent rickets type 1A. J Clin Res Pediatr Endocrinol  2019,11(1),34-40","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.6065\/apem.2019.24.2.137","volume":"24","author":"Kim Y.M.","year":"2019","unstructured":"Kim Y.M.; Jang Y.Y.; Jeong J.E.; Park H.J.; Jang J.H.; Kim J.K.; A case of vitamin D hydroxylation-deficient rickets type 1A caused by 2 novel pathogenic variants in CYP27B1 gene. Ann Pediatr Endocrinol Metab  2019,24(2),137-141","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13023-020-01558-7","volume":"15","author":"Li Y.","year":"2020","unstructured":"Li Y.; Yuan X.; Chen R.; Clinical and genetic analysis of two Chinese families with vitamin D-dependent rickets type IA and follow-up. Orphanet J Rare Dis  2020,15(1),273","journal-title":"Orphanet J Rare Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1359\/jbmr.1999.14.5.730","volume":"14","author":"Smith S.J.","year":"1999","unstructured":"Smith S.J.; Rucka A.K.; Berry J.L.; Novel mutations in the 1alpha-hydroxylase (P450c1) gene in three families with pseudovitamin D-deficiency rickets resulting in loss of functional enzyme activity in blood-derived macrophages. J Bone Miner Res  1999,14(5),730-739","journal-title":"J Bone Miner Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"39114","DOI":"10.1074\/jbc.M608006200","volume":"281","author":"Chen H.","year":"2006","unstructured":"Chen H.; Hewison M.; Adams J.S.; Functional characterization of heterogeneous nuclear ribonuclear protein C1\/C2 in vitamin D resistance: A novel response element-binding protein. J Biol Chem  2006,281(51),39114-39120","journal-title":"J Biol Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/bonekey.2014.5","volume":"3","author":"Feldman D.","year":"2014","unstructured":"Feldman D.; J Malloy P.; Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets. Bonekey Rep  2014,3,510","journal-title":"Bonekey Rep"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.abb.2011.12.020","volume":"523","author":"Christakos S.","year":"2012","unstructured":"Christakos S.; Recent advances in our understanding of 1,25-dihydroxyvitamin D3 regulation of intestinal calcium absorption. Arch Biochem Biophys  2012,523(1),73-76","journal-title":"Arch Biochem Biophys"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bonr.2015.05.001","volume":"2","author":"Isojima T.","year":"2015","unstructured":"Isojima T.; Ishizawa M.; Yoshimura K.; Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR) caused by a VDR mutation: A novel mechanism of dominant inheritance. Bone Rep  2015,2,68-73","journal-title":"Bone Rep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1359\/jbmr.081216","volume":"24","author":"Zhou Y.","year":"2009","unstructured":"Zhou Y.; Wang J.; Malloy P.J.; Dolezel Z.; Feldman D.; Compound heterozygous mutations in the vitamin D receptor in a patient with heredi-tary 1,25-dihydroxyvitamin D-resistant rickets with alopecia. J Bone Miner Res  2009,24(4),643-651","journal-title":"J Bone Miner Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1002\/jbmr.484","volume":"26","author":"Malloy P.J.","year":"2011","unstructured":"Malloy P.J.; Zhou Y.; Wang J.; Hiort O.; Feldman D.; Hereditary vitamin D-resistant rickets (HVDRR) owing to a heterozygous mutation in the vitamin D receptor. J Bone Miner Res  2011,26(11),2710-2718","journal-title":"J Bone Miner Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ymgme.2013.10.014","volume":"111","author":"Malloy P.J.","year":"2014","unstructured":"Malloy P.J.; Tasic V.; Taha D.; Vitamin D receptor mutations in patients with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Mol Genet Metab  2014,111(1),33-40","journal-title":"Mol Genet Metab"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1159\/000452886","volume":"87","author":"Ben Ameur S.","year":"2017","unstructured":"Ben Ameur S.; Silve C.; Chabchoub I.; Clinical and genetic characterization of tunisian children with hereditary 1,25-dihydroxyvitamin D-resistant rickets. Horm Res Paediatr  2017,87(1),23-29","journal-title":"Horm Res Paediatr"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1515\/jpem-2017-0312","volume":"31","author":"Faiyaz-Ul-Haque M.","year":"2018","unstructured":"Faiyaz-Ul-Haque M.; AlDhalaan W.; AlAshwal A.; Hereditary 1,25-dihydroxyvitamin D-resistant rickets (HVDRR): Clinical heteroge-neity and long-term efficacious management of eight patients from four unrelated Arab families with a loss of function VDR mutation. J Pediatr Endocrinol Metab  2018,31(8),861-868","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=41","first-page":"168","volume":"158","author":"Arita K.","year":"2008","unstructured":"Arita K.; Nanda A.; Wessagowit V.; Akiyama M.; Alsaleh Q.A.; McGrath J.A.; A novel mutation in the VDR gene in hereditary vitamin D-resistant rickets. Br J Dermatol  2008,158(1),168-171","journal-title":"Br J Dermatol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000367711","volume":"83","author":"Ersoy B.","year":"2015","unstructured":"Ersoy B.; Kiremitci S.; Isojima T.; Kitanaka S.; Successful intermittent intravenous calcium treatment via the peripheral route in a patient with hereditary vitamin D-resistant rickets and alopecia. Horm Res Paediatr  2015,83(1),67-72","journal-title":"Horm Res Paediatr"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.bone.2009.06.003","volume":"45","author":"Ma N.S.","year":"2009","unstructured":"Ma N.S.; Malloy P.J.; Pitukcheewanont P.; Dreimane D.; Geffner M.E.; Feldman D.; Hereditary vitamin D resistant rickets: Identification of a novel splice site mutation in the vitamin D receptor gene and successful treatment with oral calcium therapy. Bone  2009,45(4),743-746","journal-title":"Bone"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1515\/jpem-2019-0466","volume":"33","author":"Abal\u0131 S.","year":"2020","unstructured":"Abal\u0131 S.; Tamura M.; Turan S.; Hereditary vitamin D-resistant rickets: A report of four cases with two novel variants in the VDR gene and successful use of intermittent intravenous calcium via a peripheral route. J Pediatr Endocrinol Metab  2020,33(4),557-562","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1515\/jpem-2019-0258","volume":"33","author":"Lucas J.","year":"2020","unstructured":"Lucas J.; Badia J.L.; Lucas E.; Remon A.; Cinacalcet treatment experience in hereditary vitamin D resistant rickets. J Pediatr Endocrinol Metab  2020,33(2),313-318","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fped.2018.00376","volume":"6","author":"Nicolescu R.C.","year":"2018","unstructured":"Nicolescu R.C.; Lombet J.; Cavalier E.; Vitamin D-resistant rickets and cinacalcet\u2014one more favorable experience. Front Pediatr  2018,6,376","journal-title":"Front Pediatr"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"29148","DOI":"10.1074\/jbc.M100898200","volume":"276","author":"Gardezi S.A.","year":"2001","unstructured":"Gardezi S.A.; Nguyen C.; Malloy P.J.; Posner G.H.; Feldman D.; Peleg S.; A rationale for treatment of hereditary vitamin D-resistant rickets with analogs of 1 alpha,25-dihydroxyvitamin D(3). J Biol Chem  2001,276(31),29148-29156","journal-title":"J Biol Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.3390\/ijms21186573","volume":"21","author":"Saponaro F.","year":"2020","unstructured":"Saponaro F.; Saba A.; Zucchi R.; An update on vitamin D metabolism. Int J Mol Sci  2020,21(18),6573","journal-title":"Int J Mol Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1172\/JCI98680","volume":"128","author":"Roizen J.D.","year":"2018","unstructured":"Roizen J.D.; Li D.; O\u2019Lear L.; CYP3A4 mutation causes vitamin D-dependent rickets type 3. J Clin Invest  2018,128(5),1913-1918","journal-title":"J Clin Invest"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"R23","DOI":"10.1530\/JME-20-0178","volume":"66","author":"Ho B.B.","year":"2021","unstructured":"Ho B.B.; Bergwitz C.; FGF23 signalling and physiology. J Mol Endocrinol  2021,66(2),R23-R32","journal-title":"J Mol Endocrinol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"F285","DOI":"10.1152\/ajprenal.00508.2009","volume":"299","author":"Marks J.","year":"2010","unstructured":"Marks J.; Debnam E.S.; Unwin R.J.; Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol  2010,299(2),F285-F296","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","volume":"14","author":"Beck-Nielsen S.S.","year":"2019","unstructured":"Beck-Nielsen S.S.; Mughal Z.; Haffner D.; FGF23 and its role in X-linked hypophosphatemia-related morbidity. Orphanet J Rare Dis  2019,14(1),58","journal-title":"Orphanet J Rare Dis"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","volume":"125","author":"Gaucher C.","year":"2009","unstructured":"Gaucher C.; Walrant-Debray O.; Nguyen T.M.; Esterle L.; Garab\u00e9dian M.; Jehan F.; PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets. Hum Genet  2009,125(4),401-411","journal-title":"Hum Genet"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"617738","DOI":"10.3389\/fcell.2021.617738","volume":"9","author":"Lin X.","year":"2021","unstructured":"Lin X.; Li S.; Zhang Z.; Yue H.; Clinical and genetic characteristics of 153 Chinese patients with x-linked hypophosphatemia. Front Cell Dev Biol  2021,9,617738","journal-title":"Front Cell Dev Biol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/jbmr.4035","volume":"35","author":"Zheng B.","year":"2020","unstructured":"Zheng B.; Wang C.; Chen Q.; Functional characterization of PHEX gene variants in children with X \u2010linked hypophosphatemic rickets shows no evidence of genotype-phenotype correlation. J Bone Miner Res  2020,35(9),1718-1725","journal-title":"J Bone Miner Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"699767","DOI":"10.3389\/fped.2021.699767","volume":"9","author":"Park P.G.","year":"2021","unstructured":"Park P.G.; Lim S.H.; Lee H.; Ahn Y.H.; Cheong H.I.; Kang H.G.; Genotype and phenotype analysis in x-linked hypophosphatemia. Front Pediatr  2021,9,699767","journal-title":"Front Pediatr"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"688309","DOI":"10.3389\/fendo.2021.688309","volume":"12","author":"Baroncelli G.I.","year":"2021","unstructured":"Baroncelli G.I.; Mora S.; X-linked hypophosphatemic rickets: Multisystemic disorder in children requiring multidisciplinary management. Front Endocrinol  2021,12,688309","journal-title":"Front Endocrinol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"694","DOI":"10.3171\/2015.10.PEDS15273","volume":"17","author":"Vega R.A.","year":"2016","unstructured":"Vega R.A.; Opalak C.; Harshbarger R.J.; Hypophosphatemic rickets and craniosynostosis: A multicenter case series. J Neurosurg Pediatr  2016,17(6),694-700","journal-title":"J Neurosurg Pediatr"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.arcped.2021.09.001","volume":"28","author":"Houillier P.","year":"2021","unstructured":"Houillier P.; Salles J.P.; Biochemical assessment of phosphate homeostasis. Arch Pediatr  2021,28(7),588-593","journal-title":"Arch Pediatr"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1172\/JCI109930","volume":"66","author":"Drezner M.K.","year":"1980","unstructured":"Drezner M.K.; Lyles K.W.; Haussler M.R.; Harrelson J.M.; Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treat-ment of X-linked hypophosphatemic rickets and osteomalacia. J Clin Invest  1980,66(5),1020-1032","journal-title":"J Clin Invest"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-019-0152-5","volume":"15","author":"Haffner D.","year":"2019","unstructured":"Haffner D.; Emma F.; Eastwood D.M.; Clinical practice recommendations for the diagnosis and management of X-linked hypophos-phataemia. Nat Rev Nephrol  2019,15(7),435-455","journal-title":"Nat Rev Nephrol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"White K.E.","year":"2000","unstructured":"White K.E.; Evans W.E.; O\u2019Riordan J.L.H.; Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet  2000,26(3),345-348","journal-title":"Nat Genet"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"Shimada T.","year":"2002","unstructured":"Shimada T.; Muto T.; Urakawa I.; Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to prote-olytic cleavage and causes hypophosphatemia in vivo. Endocrinology  2002,143(8),3179-3182","journal-title":"Endocrinology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","volume":"60","author":"White K.E.","year":"2001","unstructured":"White K.E.; Carn G.; Lorenz-Depiereux B.; Benet-Pages A.; Strom T.M.; Econs M.J.; Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23. Kidney Int  2001,60(6),2079-2086","journal-title":"Kidney Int"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"8771","DOI":"10.3390\/ijerph18168771","volume":"18","author":"Mameli C.","year":"2021","unstructured":"Mameli C.; Sangiorgio A.; Colombo V.; Autosomal dominant hypophosphatemic rickets: A case report and review of the literature. Int J Environ Res Public Health  2021,18(16),8771","journal-title":"Int J Environ Res Public Health"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00774-009-0111-5","volume":"28","author":"Gribaa M.","year":"2010","unstructured":"Gribaa M.; Younes M.; Bouyacoub Y.; An autosomal dominant hypophosphatemic rickets phenotype in a Tunisian family caused by a new FGF23 missense mutation. J Bone Miner Metab  2010,28(1),111-115","journal-title":"J Bone Miner Metab"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12098-020-03335-7","volume":"88","author":"Sandal S.","year":"2021","unstructured":"Sandal S.; Arora V.; Verma I.C.; Hypophosphatemic rickets with R179W mutation in FGFR23 gene - a rare but treatable cause of refractory rickets. Indian J Pediatr  2021,88(1),61-63","journal-title":"Indian J Pediatr"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00223-019-00597-y","volume":"105","author":"Liu C.","year":"2019","unstructured":"Liu C.; Zhao Z.; Wang O.; Earlier onset in autosomal dominant hypophosphatemic rickets of R179 than R176 mutations in fibroblast growth factor 23: Report of 20 Chinese cases and review of the literature. Calcif Tissue Int  2019,105(5),476-486","journal-title":"Calcif Tissue Int"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1210\/jc.2015-2391","volume":"100","author":"Kapelari K.","year":"2015","unstructured":"Kapelari K.; K\u00f6hle J.; Kotzot D.; H\u00f6gler W.; Iron supplementation associated with loss of phenotype in autosomal dominant hypophos-phatemic rickets. J Clin Endocrinol Metab  2015,100(9),3388-3392","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00198-020-05649-w","volume":"32","author":"Liu C.","year":"2021","unstructured":"Liu C.; Li X.; Zhao Z.; Iron deficiency plays essential roles in the trigger, treatment, and prognosis of autosomal dominant hypophos-phatemic rickets. Osteoporos Int  2021,32(4),737-745","journal-title":"Osteoporos Int"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jbmr.3878","volume":"35","author":"Imel E.A.","year":"2020","unstructured":"Imel E.A.; Liu Z.; Coffman M.; Acton D.; Mehta R.; Econs M.J.; Oral iron replacement normalizes fibroblast growth factor 23 in iron\u2010deficient patients with autosomal dominant hypophosphatemic rickets. J Bone Miner Res  2020,35(2),231-238","journal-title":"J Bone Miner Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ng1868","volume":"38","author":"Lorenz-Depiereux B.","year":"2006","unstructured":"Lorenz-Depiereux B.; Bastepe M.; Benet-Pag\u00e8s A.; DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone ma-trix protein in the regulation of phosphate homeostasis. Nat Genet  2006,38(11),1248-1250","journal-title":"Nat Genet"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/jbmr.105","volume":"25","author":"M\u00e4kitie O.","year":"2010","unstructured":"M\u00e4kitie O.; Pereira R.C.; Kaitila I.; Long-term clinical outcome and carrier phenotype in autosomal recessive hypophosphatemia caused by a novel DMP1 mutation. J Bone Miner Res  2010,25(10),2165-2174","journal-title":"J Bone Miner Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/ng1905","volume":"38","author":"Feng J.Q.","year":"2006","unstructured":"Feng J.Q.; Ward L.M.; Liu S.; Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet  2006,38(11),1310-1315","journal-title":"Nat Genet"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ajhg.2010.01.010","volume":"86","author":"Levy-Litan V.","year":"2010","unstructured":"Levy-Litan V.; Hershkovitz E.; Avizov L.; Autosomal-recessive hypophosphatemic rickets is associated with an inactivation mutation in the ENPP1 gene. Am J Hum Genet  2010,86(2),273-278","journal-title":"Am J Hum Genet"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"116111","DOI":"10.1016\/j.bone.2021.116111","volume":"153","author":"H\u00f6ppner J.","year":"2021","unstructured":"H\u00f6ppner J.; Kornak U.; Sinningen K.; Rutsch F.; Oheim R.; Grasemann C.; Autosomal recessive hypophosphatemic rickets type 2 (ARHR2) due to ENPP1-deficiency. Bone  2021,153,116111","journal-title":"Bone"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000354661","volume":"81","author":"Brachet C.","year":"2014","unstructured":"Brachet C.; Mansbach A.L.; Clerckx A.; Deltenre P.; Heinrichs C.; Hearing loss is part of the clinical picture of ENPP1 loss of function muta-tion. Horm Res Paediatr  2014,81(1),63-66","journal-title":"Horm Res Paediatr"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/jbmr.3938","volume":"35","author":"Kotwal A.","year":"2020","unstructured":"Kotwal A.; Ferrer A.; Kumar R.; Clinical and biochemical phenotypes in a family with ENPP1 mutations. J Bone Miner Res  2020,35(4),662-670","journal-title":"J Bone Miner Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.bone.2014.07.009","volume":"67","author":"Kinoshita Y.","year":"2014","unstructured":"Kinoshita Y.; Hori M.; Taguchi M.; Fukumoto S.; Functional analysis of mutant FAM20C in Raine syndrome with FGF23-related hypophos-phatemia. Bone  2014,67,145-151","journal-title":"Bone"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1002\/ajmg.a.37159","volume":"167","author":"Seidahmed M.Z.","year":"2015","unstructured":"Seidahmed M.Z.; Alazami A.M.; Abdelbasit O.B.; Report of a case of Raine syndrome and literature review. Am J Med Genet A  2015,167(10),2394-2398","journal-title":"Am J Med Genet A"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ejmg.2014.07.001","volume":"57","author":"Faundes V.","year":"2014","unstructured":"Faundes V.; Castillo-Taucher S.; Gonzalez-Hormazabal P.; Chandler K.; Crosby A.; Chioza B.; Raine syndrome: An overview. Eur J Med Genet  2014,57(9),536-542","journal-title":"Eur J Med Genet"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/jbmr.1850","volume":"28","author":"Rafaelsen S.H.","year":"2013","unstructured":"Rafaelsen S.H.; Raeder H.; Fagerheim A.K.; Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification. J Bone Miner Res  2013,28(6),1378-1385","journal-title":"J Bone Miner Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13023-020-01373-0","volume":"15","author":"Mameli C.","year":"2020","unstructured":"Mameli C.; Zichichi G.; Mahmood N.; Natural history of non-lethal Raine syndrome during childhood. Orphanet J Rare Dis  2020,15(1),93","journal-title":"Orphanet J Rare Dis"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00223-020-00694-3","volume":"107","author":"Eltan M.","year":"2020","unstructured":"Eltan M.; Alavanda C.; Yavas Abali Z.; A rare cause of hypophosphatemia: Raine syndrome changing clinical features with age. Calcif Tissue Int  2020,107(1),96-103","journal-title":"Calcif Tissue Int"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1086\/427956","volume":"76","author":"White K.E.","year":"2005","unstructured":"White K.E.; Cabral J.M.; Davis S.I.; Mutations that cause osteoglophonic dysplasia define novel roles for FGFR1 in bone elongation. Am J Hum Genet  2005,76(2),361-367","journal-title":"Am J Hum Genet"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1055\/s-0037-1602816","volume":"6","author":"Kuthiroly S.","year":"2017","unstructured":"Kuthiroly S.; Yesodharan D.; Ghosh A.; White K.; Nampoothiri S.; Osteoglophonic dysplasia: Phenotypic and radiological clues. J Pediatr Genet  2017,6(4),247-251","journal-title":"J Pediatr Genet"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/jbmr.340","volume":"26","author":"Carpenter T.O.","year":"2011","unstructured":"Carpenter T.O.; Imel E.A.; Holm I.A.; Jan de Beur S.M.; Insogna K.L.; A clinician\u2019s guide to X-linked hypophosphatemia. J Bone Miner Res  2011,26(7),1381-1388","journal-title":"J Bone Miner Res"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11657-021-00879-9","volume":"16","author":"Al Juraibah F.","year":"2021","unstructured":"Al Juraibah F.; Al Amiri E.; Al Dubayee M.; Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries. Arch Osteoporos  2021,16(1),52","journal-title":"Arch Osteoporos"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","volume":"378","author":"Carpenter T.O.","year":"2018","unstructured":"Carpenter T.O.; Whyte M.P.; Imel E.A.; Burosumab therapy in children with x-linked hypophosphatemia. N Engl J Med  2018,378(21),1987-1998","journal-title":"N Engl J Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","volume":"393","author":"Imel E.A.","year":"2019","unstructured":"Imel E.A.; Glorieux F.H.; Whyte M.P.; Burosumab versus conventional therapy in children with X-linked hypophosphataemia: A ran-domised, active-controlled, open-label, phase 3 trial. Lancet  2019,393(10189),2416-2427","journal-title":"Lancet"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41581-019-0159-y","volume":"15","author":"Levi M.","year":"2019","unstructured":"Levi M.; Gratton E.; Forster I.C.; Mechanisms of phosphate transport. Nat Rev Nephrol  2019,15(8),482-500","journal-title":"Nat Rev Nephrol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1086\/499410","volume":"78","author":"Lorenz-Depiereux B.","year":"2006","unstructured":"Lorenz-Depiereux B.; Benet-Pages A.; Eckstein G.; Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3. Am J Hum Genet  2006,78(2),193-201","journal-title":"Am J Hum Genet"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1681\/ASN.2013101085","volume":"25","author":"Dasgupta D.","year":"2014","unstructured":"Dasgupta D.; Wee M.J.; Reyes M.; Mutations in SLC34A3\/] NPT2c are associated with kidney stones and nephrocalcinosis. J Am Soc Nephrol  2014,25(10),2366-2375","journal-title":"J Am Soc Nephrol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"4433","DOI":"10.1210\/jc.2009-1535","volume":"94","author":"Tencza A.L.","year":"2009","unstructured":"Tencza A.L.; Ichikawa S.; Dang A.; Hypophosphatemic rickets with hypercalciuria due to mutation in SLC34A3\/type IIc sodium-phosphate cotransporter: Presentation as hypercalciuria and nephrolithiasis. J Clin Endocrinol Metab  2009,94(11),4433-4438","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-5-1","volume":"5","author":"Mejia-Gaviria N.","year":"2010","unstructured":"Mejia-Gaviria N.; Gil-Pe\u00f1a H.; Coto E.; P\u00e9rez-Men\u00e9ndez T.M.; Santos F.; Genetic and clinical peculiarities in a new family with hereditary hypophosphatemic rickets with hypercalciuria: A case report. Orphanet J Rare Dis  2010,5(1),1","journal-title":"Orphanet J Rare Dis"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/ajmg.a.33832","volume":"155","author":"Phulwani P.","year":"2011","unstructured":"Phulwani P.; Bergwitz C.; Jaureguiberry G.; Rasoulpour M.; Estrada E.; Hereditary hypophosphatemic rickets with hypercalciuria and nephro-lithiasis-Identification of a novel SLC34A3\/NaPi-IIc mutation. Am J Med Genet A  2011,155(3),626-633","journal-title":"Am J Med Genet A"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1210\/clinem\/dgaa217","volume":"105","author":"Gordon R.J.","year":"2020","unstructured":"Gordon R.J.; Li D.; Doyle D.; Zaritsky J.; Levine M.A.; Digenic heterozygous mutations in SLC34A3 and SLC34A1 cause dominant hypo-phosphatemic rickets with hypercalciuria. J Clin Endocrinol Metab  2020,105(7),2392-2400","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1515\/jpem-2020-0624","volume":"34","author":"Turan I.","year":"2021","unstructured":"Turan I.; Erdem S.; Kotan L.D.; Experience with the targeted next-generation sequencing in the diagnosis of hereditary hypophos-phatemic rickets. J Pediatr Endocrinol Metab  2021,34(5),639-648","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1210\/clinem\/dgz260","volume":"105","author":"Cebeci AN","year":"2020","unstructured":"Cebeci AN; Zou M; BinEssa HA; Mutation of SGK3, a novel regulator of renal phosphate transport, causes autosomal dominant hypophosphatemic rickets. J Clin Endocrinol Metab  2020,105(6),1840-1850","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/ki.2011.60","volume":"80","author":"Trepiccione F.","year":"2011","unstructured":"Trepiccione F.; Capasso G.; SGK3: A novel regulator of renal phosphate transport? Kidney Int  2011,80(1),13-15","journal-title":"Kidney Int"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1210\/jc.2016-4048","volume":"102","author":"Hawkes C.P.","year":"2017","unstructured":"Hawkes C.P.; Li D.; Hakonarson H.; Meyers K.E.; Thummel K.E.; Levine M.A.; CYP3A4 induction by rifampin: An alternative pathway for vitamin D inactivation in patients with CYP24A1 mutations. J Clin Endocrinol Metab  2017,102(5),1440-1446","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1053\/j.ajkd.2018.12.026","volume":"73","author":"Bertholet-Thomas A.","year":"2019","unstructured":"Bertholet-Thomas A.; Tram N.; Dubourg L.; Lemoine S.; Molin A.; Bacchetta J.; Fluconazole as a new therapeutic tool to manage patients with NPTIIc (SLC34A3) mutation: A case report. Am J Kidney Dis  2019,73(6),886-889","journal-title":"Am J Kidney Dis"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1530\/EJE-20-0275","volume":"183","author":"Thiele S.","year":"2020","unstructured":"Thiele S.; Werner R.; Stubbe A.; Hiort O.; Hoeppner W.; Validation of a next-generation sequencing (NGS) panel to improve the diagnosis of X-linked hypophosphataemia (XLH) and other genetic disorders of renal phosphate wasting. Eur J Endocrinol  2020,183(5),497-504","journal-title":"Eur J Endocrinol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/jhg.2012.56","volume":"57","author":"Beck-Nielsen S.S.","year":"2012","unstructured":"Beck-Nielsen S.S.; Brixen K.; Gram J.; Brusgaard K.; Mutational analysis of PHEX, FGF23, DMP1, SLC34A3 and CLCN5 in patients with hypophosphatemic rickets. J Hum Genet  2012,57(7),453-458","journal-title":"J Hum Genet"}],"container-title":["Current Pediatric Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396319666221205123402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211578\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573396319666221205123402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T06:55:57Z","timestamp":1724136957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211578\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":104,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573396319666221205123402","relation":{},"ISSN":["1573-3963"],"issn-type":[{"type":"print","value":"1573-3963"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-04-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}